IMAX files Form 144 to sell 15,746 shares

IMAX Corp. filed a Form 144 to sell 15,746 shares of Common Stock, registered for sale on 04/15/2026 on the NYSE.

Rhea-AI Filing Summary

IMAX Corp. filed a Form 144 to sell 15,746 shares of Common Stock, registered for sale on 04/15/2026 on the NYSE. The filing notes the securities were acquired as compensation via stock options on 06/07/2016 and the planned sale method is "cashless exercise / same-day sale." The filing lists recent insider dispositions by Richard Gelfond totaling multiple transactions between 03/10/2026 and 04/14/2026, including sales of 121,220; 135,046; 97,462 shares on several dates with reported proceeds in the filing.

Insights

Corporate Governance Analyst

Form 144 records a planned sale of 15,746 shares and multiple recent insider dispositions.

The filing registers 15,746 shares for sale on 04/15/2026, describing the lot as acquired via stock options on 06/07/2016 and to be sold via cashless exercise / same-day sale. The disclosure lists several recent sales by Richard Gelfond between 03/10/2026 and 04/14/2026 with share counts and proceeds reported.

These entries document routine affiliate dispositions and provide transparency on timing and proceeds; stakeholder interpretation depends on overall holdings not shown in the excerpt.

Key Figures

Registered shares to be sold: 15,746 shares Acquisition date: 06/07/2016 Recent sale example: 121,220 shares +3 more

6 metrics

Registered shares to be sold 15,746 shares registered for sale on 04/15/2026

Acquisition date 06/07/2016 acquired as compensation — Stock Options

Recent sale example 121,220 shares sale by Richard Gelfond on 03/10/2026

Recent sale example 135,046 shares sale by Richard Gelfond on 04/10/2026

Recent sale example 97,462 shares sale by Richard Gelfond on 04/13/2026

Proceeds example $4,860,837.15 proceeds reported for 121,220-share sale on 03/10/2026

Key Terms

Form 144, cashless exercise / same-day sale, acquired as compensation -- Stock Options

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

cashless exercise / same-day sale financial

"Compensation -- Cashless exercise / same-day sale"

acquired as compensation -- Stock Options financial

"Acquired as compensation -- Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IMAX's Form 144 show about planned insider sales?

The Form 144 registers 15,746 shares for sale on 04/15/2026. It states the shares were acquired via stock options on 06/07/2016 and will be sold by cashless exercise / same-day sale.

Who reported recent sales in the IMAX filing and when?

Richard Gelfond reported multiple sales between 03/10/2026 and 04/14/2026. The filing lists individual transactions with share counts and proceeds for each reported date.

How many shares did Richard Gelfond sell recently according to the Form 144?

The filing lists several sales including 121,220, 135,046, and 97,462 shares on specific dates between 03/10/2026 and 04/14/2026, each with reported proceeds.

Were the shares in IMAX's Form 144 acquired as compensation?

Yes; the filing states the securities were acquired as compensation — Stock Options on 06/07/2016, indicating the registered lot derives from option-related compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 05:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000944011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMAX Corporation
SEC File Number	001-35066
Address of Issuer	2525 Speakman Drive Mississauga Unknown L5K 1B1
Phone	1-905-403-6457
Name of Person for Whose Account the Securities are To Be Sold	Richard Gelfond
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	15746	583546.76	53993017	04/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2016	Acquired as compensation -- Stock Options	Issuer			15746	06/07/2016	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	03/10/2026	121220	4860837.15
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/10/2026	135046	5106872.53
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/02/2026	12037	481520.93
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/06/2026	12987	522883.89
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/13/2026	97462	3620966.7
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	04/14/2026	6924	256657.45

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 12/9/2025, that is intended to comply with Rule 10b5-1(c).
Date of Notice	04/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Richard Gelfond
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)